CD8A and myocarditis: Previous studies have shown a marked sex bias in CVB3 myocarditis susceptibility, with males developing autoimmune CD8+ effector T cells and myocarditis when administered 102 or greater PFU of CVB3, whereas females are resistant to disease at these lower virus doses [44], [55], [57], [59].